Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
- Resource Type
- Article
- Source
- Journal of Thoracic Oncology; 20240101, Issue: Preprints
- Subject
- Language
- ISSN
- 15560864; 15561380